Brooks Gabriel
Known title: Chief Medical OfficerCIK: 0001997809
Associated companies
Transaction History
| SLDB | ▼ Sell | Open Market | 0 | $0 | 2/18/2026 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 10,937 | — | 2/13/2026 | View on chart |
| SLDB | ▼ Sell | Open Market | 12,616 | $81K | 2/4/2026 | View on chart |
| SLDB | ▼ Sell | Open Market | 28,335 | $182K | 2/2/2026 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 28,225 | — | 1/31/2026 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 58,847 | — | 1/29/2026 | View on chart |
| SLDB | ▼ Sell | Open Market | 2,895 | $17K | 10/20/2025 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 9,750 | — | 10/18/2025 | View on chart |
| SLDB | ▼ Sell | Open Market | 3,256 | $13K | 2/14/2025 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 10,937 | — | 2/13/2025 | View on chart |
| SLDB | ▼ Sell | Open Market | 2,923 | $19K | 10/21/2024 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 9,750 | — | 10/18/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
SLDB Featured in After-Market Movers List
Solid Biosciences was included in a Benzinga list of healthcare stocks moving in Friday's after-market session. The stock is currently trading near its 52-week low, with an RSI of 20.5 indicating oversold conditions. Analysts maintain an average price target of $18.62, which is significantly higher than the current trading range.
SLDB Featured in After-Market Movers List. Solid Biosciences was included in a Benzinga list of healthcare stocks moving in Friday's after-market session. The stock is currently trading near its 52-week low, with an RSI of 20.5 indicating oversold conditions. Analysts maintain an average price target of $18.62, which is significantly higher than the current trading range.